17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Human, Animal and Plant Health Benefits of Glucosinolates and Strategies for Enhanced Bioactivity: A Systematic Review

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Glucosinolates (GSs) are common anionic plant secondary metabolites in the order Brassicales. Together with glucosinolate hydrolysis products (GSHPs), they have recently gained much attention due to their biological activities and mechanisms of action. We review herein the health benefits of GSs/GSHPs, approaches to improve the plant contents, their bioavailability and bioactivity. In this review, only literature published between 2010 and March 2020 was retrieved from various scientific databases. Findings indicate that these compounds (natural, pure, synthetic, and derivatives) play an important role in human/animal health (disease therapy and prevention), plant health (defense chemicals, biofumigants/biocides), and food industries (preservatives). Overall, much interest is focused on in vitro studies as anti-cancer and antimicrobial agents. GS/GSHP levels improvement in plants utilizes mostly biotic/abiotic stresses and short periods of phytohormone application. Their availability and bioactivity are directly proportional to their contents at the source, which is affected by methods of food preparation, processing, and extraction. This review concludes that, to a greater extent, there is a need to explore and improve GS-rich sources, which should be emphasized to obtain natural bioactive compounds/active ingredients that can be included among synthetic and commercial products for use in maintaining and promoting health. Furthermore, the development of advanced research on compounds pharmacokinetics, their molecular mode of action, genetics based on biosynthesis, their uses in promoting the health of living organisms is highlighted.

          Related collections

          Most cited references184

          • Record: found
          • Abstract: not found
          • Article: not found

          Glucosinolates, structures and analysis in food

          Don Clarke (2010)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction

            Summary Myocardial infarction (MI), a leading cause of death around the world, displays a complex pattern of inheritance 1,2 . When MI occurs early in life, the role of inheritance is substantially greater 1 . Previously, rare mutations in low-density lipoprotein (LDL) genes have been shown to contribute to MI risk in individual families 3–8 whereas common variants at more than 45 loci have been associated with MI risk in the population 9–15 . Here, we evaluate the contribution of rare mutations to MI risk in the population. We sequenced the protein-coding regions of 9,793 genomes from patients with MI at an early age (≤50 years in males and ≤60 years in females) along with MI-free controls. We identified two genes where rare coding-sequence mutations were more frequent in cases versus controls at exome-wide significance. At low-density lipoprotein receptor (LDLR), carriers of rare, damaging mutations (3.1% of cases versus 1.3% of controls) were at 2.4-fold increased risk for MI; carriers of null alleles at LDLR were at even higher risk (13-fold difference). This sequence-based estimate of the proportion of early MI cases due to LDLR mutations is remarkably similar to an estimate made more than 40 years ago using total cholesterol 16 . At apolipoprotein A-V (APOA5), carriers of rare nonsynonymous mutations (1.4% of cases versus 0.6% of controls) were at 2.2-fold increased risk for MI. When compared with non-carriers, LDLR mutation carriers had higher plasma LDL cholesterol whereas APOA5 mutation carriers had higher plasma triglycerides. Recent evidence has connected MI risk with coding sequence mutations at two genes functionally related to APOA5, namely lipoprotein lipase 15,17 and apolipoprotein C3 18,19 . When combined, these observations suggest that, beyond LDL cholesterol, disordered metabolism of triglyceride-rich lipoproteins contributes to MI risk.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer.

              Diets high in cruciferous vegetables are associated with lower risk of incidence of prostate cancer, including aggressive forms of this disease. Human intervention studies with cruciferous vegetable-rich diets also demonstrate modulation of gene expression in important pathways in prostate cells.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Molecules
                Molecules
                molecules
                Molecules
                MDPI
                1420-3049
                12 August 2020
                August 2020
                : 25
                : 16
                : 3682
                Affiliations
                [1 ]Smart Farm Research Center, Korea Institute of Science and Technology (KIST), Gangneung, Gangwon 25451, Korea; wairimusylvia@ 123456kist.re.kr
                [2 ]College of Veterinary Medicine and Biomedical Sciences, Sokoine University of Agriculture, Morogoro 25523, Tanzania; gerald.misinzo@ 123456sacids.org (G.M.); gaymary.bakari@ 123456sua.ac.tz (G.B.)
                [3 ]SACIDS Africa Centre of Excellence for Infectious Diseases, Sokoine University of Agriculture, Morogoro 25523, Tanzania
                Author notes
                [* ]Correspondence: hykim@ 123456kist.re.kr ; Tel.: +82-33-650-3580
                Author information
                https://orcid.org/0000-0003-1827-6403
                https://orcid.org/0000-0003-1986-2025
                Article
                molecules-25-03682
                10.3390/molecules25163682
                7464879
                32806771
                84e544ce-d4a0-4d96-a332-a0d299414984
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 24 June 2020
                : 10 August 2020
                Categories
                Review

                glucosinolates,glucosinolate hydrolysis products,natural compounds,secondary metabolites,bioactivity,improvement,bioavailability

                Comments

                Comment on this article